Premium
Fenoterol Inhalation Powder and Aerosol in the Treatment of Asthma
Author(s) -
Kiviranta K.
Publication year - 1985
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/j.1398-9995.1985.tb00237.x
Subject(s) - fenoterol , inhalation , asthma , aerosol , medicine , anesthesia , chemistry , immunology , organic chemistry
Twenty patients with asthma were studied. They were given either fenoterol powder or fenoterol MDI for 2‐week periods using a double‐blind cross‐over design. Identical doses of fenoterol (0.2–0.4 mg 2–4 times daily) were given to an individual patient throughout the 4‐week study period. Both forms of treatment produced an almost identical bronchodilation, and there were no statistically significant differences in symptoms or side effects. It is concluded that fenoterol powder and fenoterol aerosol are equally effective.